abstract |
Methods for the treatment, management or prevention of apnea and apneandisorders, or symptoms thereof, are disclosed, using a therapeutically effectivenamount of substantially optically pure R (+) ondansetron, or a pharmaceuticallynacceptable salt thereof, substantially free of its S (-) stereoisomer. |